Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individuals
- PMID: 22574621
- PMCID: PMC3654839
- DOI: 10.1111/j.1468-1293.2012.01024.x
Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individuals
Abstract
Objectives: Distal leg epidermal nerve fibre density (ENFD) is a validated predictor of small unmyelinated nerve fibre damage and neuropathy risk in HIV infection. As pre-existing damage may increase the risk of neuropathy following antiretroviral (ARV) therapy, particularly when the regimen contains stavudine (d4T), we assessed the relationship between ENFD and various parameters including mitochondrial factors in HIV-infected Thai individuals naïve to ARV therapy.
Methods: Distal leg and proximal thigh ENFDs were quantified in HIV-infected Thai individuals without neuropathy prior to randomization to a HIV clinical trial that focused on mitochondrial toxicity issues. We assessed their association with various clinical and immunovirological parameters as well as with peripheral blood mononuclear cell (PBMC) mitochondrial (mt) DNA copies/cell, oxidative phosphorylation (OXPHOS) complex I (CI) and complex IV (CIV) enzyme activities, and mt 8-oxo-deoxyguanine (8-oxo-dG) break frequencies.
Results: In 132 subjects, the median (interquartile range) ENFD (fibres/mm) values were 21.0 (16.2-26.6) for the distal leg and 31.7 (26.2-40.0) for the proximal thigh. By linear regression, lower CD4 count (P < 0.01), older age (P < 0.01), increased body mass index (BMI) (P = 0.04), increased height (P = 0.02), and higher PBMC OXPHOS activity as measured by CIV activity (P = 0.02) were associated with lower distal leg ENFD.
Conclusions: Older age, increased height, higher BMI, poorer immunological status and higher PBMC OXPHOS activity are associated with lower distal leg ENFD in HIV-infected subjects free of neuropathy prior to initiation of first-time ARV therapy.
© 2012 British HIV Association.
Figures


References
-
- Keswani SC, Pardo CA, Cherry CL, Hoke A, McArthur JC. HIV-associated sensory neuropathies. Aids. 2002;16:2105–17. - PubMed
-
- England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:177–84. - PubMed
-
- Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006;66:1679–87. - PubMed
-
- Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002;58:115–9. - PubMed
-
- Gerschenson M, Shiramizu B, LiButti DE, Shikuma CM. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Antivir Ther. 2005;10 (Suppl 2):M83–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P20RR011091/RR/NCRR NIH HHS/United States
- R01 NS063932/NS/NINDS NIH HHS/United States
- U54 RR026136/RR/NCRR NIH HHS/United States
- R01 AI074554/AI/NIAID NIH HHS/United States
- P30 MH075673/MH/NIMH NIH HHS/United States
- R01AI074554/AI/NIAID NIH HHS/United States
- R01 NS044807/NS/NINDS NIH HHS/United States
- U54RR026136/RR/NCRR NIH HHS/United States
- U54 MD007584/MD/NIMHD NIH HHS/United States
- P30MH075673/MH/NIMH NIH HHS/United States
- NS44807/NS/NINDS NIH HHS/United States
- R25 TW009345/TW/FIC NIH HHS/United States
- R01NS063932/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials